VLX600
CAS No. 327031-55-0
VLX600( —— )
Catalog No. M21963 CAS No. 327031-55-0
VLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 43 | Get Quote |
|
10MG | 69 | Get Quote |
|
25MG | 142 | Get Quote |
|
50MG | 237 | Get Quote |
|
100MG | 405 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVLX600
-
NoteResearch use only, not for human use.
-
Brief DescriptionVLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent.
-
DescriptionVLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent.?It acts by reducing mitochondrial oxidative phosphorylation in tumor cells.VLX600 as a drug that is preferentially active against quiescent cells in colon cancer 3-D microtissues.?The anticancer activity is associated with reduced mitochondrial respiration, leading to bioenergetic catastrophe and tumour cell death.?VLX600 shows enhanced cytotoxic activity under conditions of nutrient starvation.?Importantly, VLX600 displays tumour growth inhibition in vivo.?(In Vivo):VLX600 (16?mg/kg; i.v.; every third day for 16 days) shows anti-tumor activity in human tumor xenografts.
-
In VitroVLX600 (6?μM; 72 hours) induces an autophagic response.VLX600 is cytotoxic to HCT116 spheroids. VLX600 induces a HIF-1α-dependent glycolytic response. VLX600 inhibits oxygen consumption in HCT116 cells. VLX600 inhibits phosphorylation of the mTOR downstream effectors 4EBP1 and p70-S6K by an HIF-1α-independent mechanism. VLX600 preferentially leads to decreased ATP levels in cancer but not normal cells.Cell Proliferation Assay Cell Line:HCT116, HT29, SW620, HT8, DLD and RKO cells Concentration:0.1, 1, 10, 100μM Incubation Time:72 hours Result:Inhibited the proliferation of these cells.Western Blot Analysis Cell Line:HCT116 cells Concentration:6?μM Incubation Time:72?hoursResult:LC3-II was induced.
-
In VivoVLX600 (16?mg/kg; i.v.; every third day for 16 days) shows anti-tumor activity in human tumor xenografts. Animal Model:NMRI nu/nu mice (HCT116 and HT29 colon cancer xenografts)Dosage:16?mg/kg Administration:Intravenously; every third day for 16 days Result:Anti-tumor activity was observed in both HCT116 and HT29 colon cancer xenografts.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptoroxidative phosphorylation (OXPHOS)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number327031-55-0
-
Formula Weight317.35
-
Molecular FormulaC17H15N7
-
Purity>98% (HPLC)
-
SolubilityDMSO:8 mg/ml(25.21 mM)
-
SMILESC\C(=N/Nc1nnc2c(n1)[nH]c1c(C)cccc21)c1ccccn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
D-Asparagine
D-Asparagine is a source of nitrogen for yeast strains. D-Asparagine is a competitive inhibitor of L-Asparagine hydrolysis (Ki = 0.24 mM).
-
Fibrinopeptide A, hu...
Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which binds to the central region of fibrinogen and catalyzes cleavage of the 2 short peptides, the 16-residue fibrinopeptide A (FpA) and the 14-residue fibrinopeptide B (FpB), located at the NH2-termini of the Aα and Bβ chains, respectively.
-
Tamerit
Tamerit as an efficient inhibitor of oxidative burst in monocytes.